Clinical Trial Update: COMT on Aspirin Platelets Effects (CAPE) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating the effects of COMT on aspirin platelets (CAPE) in cardiovascular disease patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Cardiovascular Diseases | Phase 4 | Status: UNKNOWN